Benzylthiouracil
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C11H10N2OS |
Molar mass | 218.276 g/mol |
WikiDoc Resources for Benzylthiouracil |
Articles |
---|
Most recent articles on Benzylthiouracil Most cited articles on Benzylthiouracil |
Media |
Powerpoint slides on Benzylthiouracil |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Benzylthiouracil at Clinical Trials.gov Trial results on Benzylthiouracil Clinical Trials on Benzylthiouracil at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Benzylthiouracil NICE Guidance on Benzylthiouracil
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Benzylthiouracil Discussion groups on Benzylthiouracil Patient Handouts on Benzylthiouracil Directions to Hospitals Treating Benzylthiouracil Risk calculators and risk factors for Benzylthiouracil
|
Healthcare Provider Resources |
Causes & Risk Factors for Benzylthiouracil |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Benzylthiouracil (BTU) is an antithyroid preparation. It is a thioamide, closely related to propylthiouracil.
Adverse effects
Benzylthiouracil has been associated with severe adverse effects, notably vasculitis and subsequent ANCA-positive glomerulonephritis, as well as isolated reports of lung damage.[1][2][3][4]
References
- ↑ Tieulie N, Huong DL, Andreu M; et al. (2002). "[ANCA associated glomerulonephritis related to benzylthiouracil]". Rev Med Interne (in French). 23 (10): 853–6. PMID 12428489.
- ↑ Kaaroud H, Khiari K, Ben Moussa F, Barbouch S, Boussema E, Ben Maïz H (2002). "[Vasculitis with renal and pulmonary involvement in a patient receiving benzylthiouracil for Graves disease]". Rev Med Interne (in French). 23 (10): 857–61. PMID 12428490.
- ↑ Braham A, Houman MH, Rais L, Ben Gborbel I, Lamloum M, Miled M (2004). "[Benzylthiouracil induced ANCA-positive vasculitis]". Presse médicale (in French). 33 (19 Pt 1): 1331–3. PMID 15615240.
- ↑ Thabet F, Sghiri R, Tabarki B, Ghedira I, Yacoub M, Essoussi AS (2006). "ANCA-associated diffuse alveolar hemorrhage due to benzylthiouracil". Eur J Pediatr. 165 (7): 435–6. doi:10.1007/s00431-005-0053-4. PMID 16622664.
- Pages with script errors
- CS1 maint: Explicit use of et al.
- CS1 maint: Multiple names: authors list
- CS1 maint: Unrecognized language
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Endocrinology